Perspective Therapeutics (CATX) Receivables - Other (2016 - 2025)
Perspective Therapeutics (CATX) has disclosed Receivables - Other for 15 consecutive years, with $10000.0 as the latest value for Q4 2025.
- Quarterly Receivables - Other fell 97.95% to $10000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10000.0 through Dec 2025, down 97.95% year-over-year, with the annual reading at $10000.0 for FY2025, 97.95% down from the prior year.
- Receivables - Other hit $10000.0 in Q4 2025 for Perspective Therapeutics, down from $487000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $487000.0 in Q4 2024 to a low of $2000.0 in Q4 2022.
- Historically, Receivables - Other has averaged $93000.0 across 5 years, with a median of $13500.0 in 2022.
- Biggest five-year swings in Receivables - Other: soared 4770.0% in 2024 and later tumbled 97.95% in 2025.
- Year by year, Receivables - Other stood at $32000.0 in 2021, then crashed by 93.75% to $2000.0 in 2022, then soared by 400.0% to $10000.0 in 2023, then skyrocketed by 4770.0% to $487000.0 in 2024, then crashed by 97.95% to $10000.0 in 2025.
- Business Quant data shows Receivables - Other for CATX at $10000.0 in Q4 2025, $487000.0 in Q4 2024, and $10000.0 in Q4 2023.